PROGRAM DESCRIPTION:
Changes in cognitive function can reflect a number of conditions, including but certainly not limited, to the mild cognitive impairment that precedes the dementia phase of Alzheimer’s disease. In this case, a woman who has exhibited some concerning cognitive lapses in her professional and family life undergoes evaluation to identify the probable pathology underlying these developments.
INTENDED AUDIENCE:
Neurologists who provide care for patients with Alzheimer’s disease or related dementias.
ACTIVITY OBJECTIVES:
After participating in this activity, clinicians should be better able to:
— Describe the new construct for understanding, diagnosing, and treating Alzheimer’s disease (AD)
— Apply contemporary approaches to the diagnosis of AD
— Identify the role of AD biomarkers in preclinical and clinical settings
FACULTY:
David A. Wolk, MD
Assistant Professor
Department of Neurology
University of Pennsylvania
Assistant Director, Penn Memory Center
Philadelphia, PA
Adam Fleisher, MD, MAS
Geriatric Neurologist
Associate Director of Brain Imaging
Banner Alzheimer’s Institute
Phoenix, AZ
CME COURSE ADVISOR
Gary J. Kennedy, MD
Director, Division of Geriatric Psychiatry
Montefiore Medical Center
Bronx, NY
